Search - tctmd.com

Displaying 401 - 420 of 605

Sort: Relevancy | Date

News Conference News ESC 2014

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Conference News ESC 2014

Observational Studies Ask How Much Medication Adherence Matters After MI

Caitlin E. Cox

August 31, 2014

News Daily News

Registry Data Confirm Increase in Bleeding with Noncardiac Surgery After PCI vs CABG

Caitlin E. Cox

August 20, 2014

News Daily News

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

L.A. McKeown

August 20, 2014

News Daily News

Updated Stable Ischemic Heart Disease Guidelines Add Advice on Diagnostic Cath

Yael L. Maxwell

August 07, 2014

News Daily News

Regional Quality-Improvement Effort Reduces Contrast-Induced AKI After PCI

Yael L. Maxwell

August 07, 2014

News Daily News

La Revascularización Híbrida Sigue Sin estar Disponible el Hospitales de EE.UU. Aunque están Probados sus Perfiles de Seguridad y Eficacia

L.A. McKeown

August 07, 2014

News Daily News

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

L.A. McKeown

August 07, 2014

News Daily News

联合血运重建有望给糖尿病患者带来福音

L.A. McKeown

July 24, 2014

News Daily News

Hybrid Revascularization a Promising Option for Diabetic Patients

L.A. McKeown

July 24, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Daily News

Transradial PCI May Improve Long-term Survival in NSTEMI

Todd Neale

July 17, 2014

News Daily News

Dialysis Patients with Complex Coronary Disease Fare Better at 5 Years with CABG vs PCI

Caitlin E. Cox

June 24, 2014

News Daily News

Manual Thrombectomy Optimizes PCI, But No Long-term Benefit in STEMI

Yael L. Maxwell

June 03, 2014

News Conference News EuroPCR 2014

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

Yael L. Maxwell

May 23, 2014

News Industry News

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 21, 2014

News Daily News

CABG Achieves Better 30-Day Outcomes vs PCI in Younger Patients, Similar 5-year Mortality

Yael L. Maxwell

May 15, 2014

News Daily News

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

April 30, 2014

News Daily News

Patients with Cardiac Arrest Fare Poorly After PCI

April 17, 2014

Advertisement

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Observational Studies Ask How Much Medication Adherence Matters After MI

Registry Data Confirm Increase in Bleeding with Noncardiac Surgery After PCI vs CABG

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

Updated Stable Ischemic Heart Disease Guidelines Add Advice on Diagnostic Cath

Regional Quality-Improvement Effort Reduces Contrast-Induced AKI After PCI

La Revascularización Híbrida Sigue Sin estar Disponible el Hospitales de EE.UU. Aunque están Probados sus Perfiles de Seguridad y Eficacia

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

联合血运重建有望给糖尿病患者带来福音

Hybrid Revascularization a Promising Option for Diabetic Patients

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Transradial PCI May Improve Long-term Survival in NSTEMI

Dialysis Patients with Complex Coronary Disease Fare Better at 5 Years with CABG vs PCI

Manual Thrombectomy Optimizes PCI, But No Long-term Benefit in STEMI

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

CABG Achieves Better 30-Day Outcomes vs PCI in Younger Patients, Similar 5-year Mortality

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

Patients with Cardiac Arrest Fare Poorly After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content